
Innolink Fund
Asia, Beijing, China, Haidian'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Innolink Fund is committed to enabling innovation empower traditional industries & deeply implements the investment layout strategy of ACE
Investor Profile
Innolink Fund has backed more than 5 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Private Equity, Series A rounds (top funding stages).
- Majority of deals are located in China.
- Strong thematic focus on Health Care, Biotechnology, Genetics.
Stage Focus
- Series C (60%)
- Private Equity (20%)
- Series A (20%)
Country Focus
- China (100%)
Industry Focus
- Health Care
- Biotechnology
- Genetics
- Life Science
- Medical Device
- Robotics
- Beauty
- Hospital
- Medical
- Air Transportation
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.